Maja Mijić

ORCID: 0000-0002-8355-1013
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease Diagnosis and Treatment
  • Liver Diseases and Immunity
  • Liver Disease and Transplantation
  • Organ Transplantation Techniques and Outcomes
  • Pediatric Hepatobiliary Diseases and Treatments
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Apelin-related biomedical research
  • Hepatitis C virus research
  • Gallbladder and Bile Duct Disorders
  • SARS-CoV-2 and COVID-19 Research
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Liver physiology and pathology
  • Drug-Induced Hepatotoxicity and Protection
  • Esophageal and GI Pathology
  • Xenotransplantation and immune response
  • Polyamine Metabolism and Applications
  • Parvovirus B19 Infection Studies
  • MRI in cancer diagnosis
  • Emotional Intelligence and Performance
  • Lung Cancer Research Studies
  • Metastasis and carcinoma case studies
  • Hydrogen's biological and therapeutic effects
  • Reproductive System and Pregnancy
  • Kawasaki Disease and Coronary Complications
  • Hemoglobinopathies and Related Disorders

Klinička bolnica Merkur
2017-2024

University of Zagreb
2017-2018

University of Rijeka
2012

Background: Derangement of liver blood tests (LBT) is frequent in patients with Coronavirus disease 2019 (COVID-19). We aimed to evaluate (a) the prevalence deranged LBT as well their association (b) clinical severity at admission and (c) 30-day outcomes among hospitalized COVID-19. Methods: Consecutive COVID-19 regional referral center over 12-month period were included. Clinical hospital (need for intensive care, mechanical ventilation, or death) analyzed. Results: occurred 2854/3812...

10.3390/jcm10184222 article EN Journal of Clinical Medicine 2021-09-17

AimTo assess the measures of disease frequency and determine clinical features primary biliary cholangitis (PBC) in two Croatian regions.MethodsDatabases tertiary hospitals, one located continental coastal region Croatia, were retrospectively searched for PBC patients diagnosed from 2007 to 2018. Epidemiologic data analysis was restricted each hospital's catchment area. We analyzed factors related response therapy event-free survival (EFS), defined as absence ascites, variceal bleeding,...

10.3325/cmj.2019.60.494 article EN cc-by-nc-nd Croatian Medical Journal 2019-12-01

Aim. The primary objective of this study was to evaluate the prevalence increased controlled attenuation parameter (CAP) and liver stiffness measurements (LSM) as surrogate markers steatosis fibrosis in transplant recipient (LTR). Secondary objectives were determine predictors CAP LSM population LTR. Methods. In prospective, cross-sectional study, we have evaluated 175 LTRs’ mean age 61 (53–65) with a functioning graft for more than one year who came regular outpatient examinations...

10.1155/2021/6657047 article EN cc-by Canadian Journal of Gastroenterology and Hepatology 2021-02-08

Nonalcoholic fatty liver disease (NAFLD) is associated with systemic changes in immune response linked chronic low-grade inflammation and progression. Semaphorins, a large family of biological modifiers, were recently recognized as one the key regulators responses, possibly also diseases. The aim this study was to identify semaphorins NAFLD their relationship steatosis fibrosis stages. In prospective, case-control study, serum semaphorin concentrations (SEMA3A, -3C, -4A, -4D, -5A -7A)...

10.3390/biomedicines10123014 article EN cc-by Biomedicines 2022-11-23

Hemophagocytic lymphohistiocytosis (HLH) is a congenital or acquired hyperinflammatory syndrome, in some cases accompanied by acute liver failure. We present case report of failure associated with HLH after COVID-19 vaccination and bring literature review the connection between vaccination. has significant mortality rate, transplantation not therapeutic option. Therefore, early recognition timely conservative treatment are corner stones reducing HLH-related morbidity mortality.

10.2147/imcrj.s417347 article EN cc-by-nc International Medical Case Reports Journal 2023-08-01

Ursodeoxycholic acid response score (URS) is a prognostic model that estimates the baseline probability of treatment after 12 months ursodeoxycholic (UDCA) therapy in patients with primary biliary cholangitis (PBC).To independently evaluate predictive performance URS model.We used cohort Slovak and Croatian treatment-naïve PBC to quantify discrimination ability using area under receiver operating characteristic curve (AUROC) its 95% confidence interval (CI). Furthermore, we evaluated...

10.1155/2021/9928065 article EN cc-by Canadian Journal of Gastroenterology and Hepatology 2021-06-22

Objective: To identify pretreatment laboratory parameters associated with treatment response and to describe the relationship between liver decompensation in patients primary biliary cholangitis treated ursodeoxycholic acid. Methods: We defined as both ALP ≤ 1.67 × ULN total bilirubin 2 ULN. Multiple logistic regression analyses were performed adjust for confounding effects of sociodemographic variables. Results: Pretreatment ((TB); OR = 0.3388, 95%CI 0.1671–0.6077), ALT (OR 0.5306,...

10.3390/jpm11060495 article EN Journal of Personalized Medicine 2021-06-01

Pseudokidney sign (PKS) is a characteristic sonographic finding of an abnormal mass with reniform appearance, and hyperechoic central region surrounded by hypoechoic area. It has been seldom documented in gastric cancer. A 75-year-old male patient presented palpable abdominal resistance the left upper quadrant ultrasound evaluation revealed well-vascularized presenting PKS. Regional lymphadenopathy was also found, working diagnosis cancer established. The suspected later verified...

10.3390/diagnostics14090896 article EN cc-by Diagnostics 2024-04-25

¶ 12 41 M small intestine no 9 G2 octreotide 20 2019 2 (died) *performed on explanted liver tissue.†diagnosis defined after insight in tissue.‡insulinoma.§extirpation of primary tumor/extirpation recurrent tumor.IIliver + pancreas.¶after second transplantation.**retransplantation for hepatic artery thrombosis.† †primary tumor: donor lungs.‡ ‡year the transplantation.

10.3325/cmj.2021.62.44 article EN cc-by-nc-nd Croatian Medical Journal 2021-02-01

To compare the long-term outcomes between liver transplant (LT) recipients with hepatocellular carcinoma (HCC) who were downstaged transarterial-chemoembolization (TACE) to Milan criteria (MC) and those initially meeting MC.This retrospective study enrolled 198 patients HCC: 38 160 met MC. Post-LT survival HCC recurrence-free evaluated. We assessed association of death recurrence TACE, baseline (age, sex, disease etiology, Model End-stage Liver Disease, tumor number sum maximum diameters,...

10.3325/cmj.2022.63.317 article EN cc-by-nc-nd Croatian Medical Journal 2022-08-01
Coming Soon ...